Systemic inflammation response index predicts overall survival in patients undergoing stereotactic radiosurgery for brain metastasis from non-small cell lung cancer
Journal of Radiation Research · 24.03.2025 · 66 (2) · 129-136
DOI: 10.1093/jrr/rrae099 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Radiation Research, online erschienen am 19.02.2025. Verfasst von Ryosuke Matsuda und 15 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurosurgery, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan. Hauptthemen laut MEDLINE: Radiosurgery, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Brain Neoplasms. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 42 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0).
Abstract (Originalsprache)
This study aimed to evaluate the prognostic value of pre-treatment blood cell counts in patients with brain metastasis (BM) from non-small cell lung cancer (NSCLC) who were treated using linear accelerator (linac)-based stereotactic radiosurgery (SRS) and fractionated stereotactic radiotherapy (fSRT) with a micro-multileaf collimator. Between January 2011 and November 2022, 271 consecutive patients underwent linac-based SRS/fSRT for BM from NSCLC. Thirty patients with insufficient blood test data during this period were excluded from this analysis. Thirty-five patients with steroid intake at the time point of the blood test and 18 patients with higher C-reactive protein were excluded. Thus, 188 patients were eventually enrolled in this study. The median follow-up period after SRS/fSRT was 21 months (range: 0–121 months), and the median survival time after SRS/fSRT was 19 months. Neutrophil–lymphocyte ratio ≥ 1.90, lymphocyte–monocyte ratio ≤ 1.67 and systemic inflammation response index (SIRI) ≥ 2.95 were unfavorable predictors of prognosis for patients who underwent SRS/fSRT for BM from NSCLC. Cox proportional-hazard multivariate analysis revealed that the SIRI was independent prognostic factors for increased risk of death. Thus, simple, less expensive, and routinely performed pre-treatment blood cell count measurements such as SIRI can predict the overall survival of patients treated with SRS/fSRT for BM from NSCLC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Neurosurgery, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
- Department of Radiation Oncology, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
- Department of Medical Informatics, Nara Medical University Hospital, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
- Department of Respiratory Medicine, Nara Medical University, 840 Shijo-cho, Kashihara, Nara 634-8522, Japan.
- Department of Internal Medicine, Heisei Memorial Hospital, 827 Shijo-cho, Kashihara, Nara 634-0813, Japan.
Zitieren
APA
Matsuda, R., Tamamoto, T., Inooka, N., Hontsu, S., Doi, A., Maeoka, R., Nakazawa, T., Morimoto, T., Yamaki, K., Miura, S., Morisaki, Y., Yokoyama, S., Kotsugi, M., Takeshima, Y., Isohashi, F., & Nakagawa, I. (2025). Systemic inflammation response index predicts overall survival in patients undergoing stereotactic radiosurgery for brain metastasis from non-small cell lung cancer. Journal of Radiation Research, 66(2), 129-136. https://doi.org/10.1093/jrr/rrae099
Vancouver
Matsuda R, Tamamoto T, Inooka N, Hontsu S, Doi A, Maeoka R, et al. Systemic inflammation response index predicts overall survival in patients undergoing stereotactic radiosurgery for brain metastasis from non-small cell lung cancer. Journal of Radiation Research. 2025;66(2):129-136. doi:10.1093/jrr/rrae099
BibTeX
@article{Matsuda2025,
author = {Matsuda, Ryosuke and Tamamoto, Tetsuro and Inooka, Nobuyoshi and Hontsu, Shigeto and Doi, Akihiro and Maeoka, Ryosuke and Nakazawa, Tsutomu and Morimoto, Takayuki and Yamaki, Kaori and Miura, Sachiko and Morisaki, Yudai and Yokoyama, Shohei and Kotsugi, Masashi and Takeshima, Yasuhiro and Isohashi, Fumiaki and Nakagawa, Ichiro},
title = {Systemic inflammation response index predicts overall survival in patients undergoing stereotactic radiosurgery for brain metastasis from non-small cell lung cancer},
journal = {Journal of Radiation Research},
year = {2025},
volume = {66},
number = {2},
pages = {129--136},
doi = {10.1093/jrr/rrae099}
}
EUVIMED